• Type of Event: Q4 and FY26 Earnings Conference Call hosted by Arihant Capital Markets Limited, consisting of management opening remarks followed by Q&A session.
  • Date and Time: Monday, June 1, 2026, at 4:00 PM IST.
  • Purpose: Discussion of Q4 and FY26 operational and financial performance, strategic growth projects, and future outlook.
  • Management Participants: Mr. Sumeet Kumar – Executive Vice President, Finance, UFlex Group; Mr. Surajit Pal – Vice President, Head of Investor Relations, UFlex Limited.
  • Presentation Availability: The transcript will be made available on the company's website at www.uflexltd.com.
  • UPSI Statement: The discussion included forward-looking statements which are predictions, projections or estimates about future events, subject to risks and uncertainties that could cause actual results to differ materially.

Financial Highlights Discussed

Q4 FY26 Performance:

  • Consolidated revenue: Rs.40,973 million (up 12.8% QoQ, 5.7% YoY)
  • EBITDA: Rs.6,265 million (up 36.3% QoQ, 31.8% YoY)
  • EBITDA margin: 15.3% (highest in last 14 quarters since Q1 FY23)
  • Normalized PAT: Rs.2,026 million
  • Consolidated sales volume: 166,879 MT (up 10.3% QoQ, 1% YoY)

FY26 Full Year Performance:

  • Consolidated revenue: Rs.155,130 million (up 2.1% YoY)
  • EBITDA: Rs.19,836 million (up 8.1% YoY)
  • EBITDA margin: 12.8% (expanded 70 bps YoY)
  • Consolidated sales volume: 649,789 MT (up 0.4% YoY)

Segment-wise Volume Performance Q4 FY26:

  • Packaging business: 38,842 MT (up 7.1% QoQ, 1.6% YoY)
  • Aseptic packaging: 15.9% sequential growth driven by seasonal demand
  • Packaging Films: 128,037 MT (up 11.4% QoQ, 0.9% YoY)

Regional Performance Packaging Films Q4 FY26:

  • India: 26,888 MT (up 6.3% QoQ, down 6.3% YoY)
  • Americas: 31,883 MT (up 23% QoQ, 18% YoY)
  • Europe: 35,367 MT (up 12.9% QoQ)
  • Middle East and Africa: 33,899 MT (up 4.6% QoQ, 1.5% YoY)

Capital Expenditure Projects:

  • Aseptic packaging facility in Egypt (12 billion capacity, commissioning expected H1 FY27)
  • WPP bag manufacturing unit in Mexico (commissioning expected H1 FY27)
  • PCR PET facility and MLP manufacturing facility in India (commissioned end of April 2026)
  • New BOPP packaging film manufacturing line at Dharwad
  • Total CWIP as of March 2026: Rs.2,169 crore, expected capitalization: Rs.1,900-2,000 crore in FY27

Financial Metrics:

  • FY26 Finance cost: Rs.777 crore
  • FY26 Depreciation: Rs.787 crore
  • Blended cost of debt: ~9%
  • Net debt to EBITDA: Improved from 4.51 in Q3 to 4.35 in Q4
  • International revenue contribution: 57% (43% domestic)

FY27 Outlook:

  • Expects better performance than FY26 driven by improved utilization of recently commissioned capacities
  • Product mix optimization and additional capacities coming online during FY27
  • Aseptic packaging volume target: ~10.5 billion packs (from 7.97 billion in FY26)
  • Packaging Solutions business expected to contribute higher EBITDA percentage (currently 40% of total)

Additional Notes Section

  • The document is a transcript of the earnings conference call containing Q&A with analysts and investors.
  • The transcript includes forward-looking statements subject to risks and uncertainties.
  • Contact information provided: Mr. Surajit Pal, VP Head of IR and Mr. Manoj Pandey, Manager IR at investorrelations@uflexltd.com.